Board of Scientific Counselors, National Center for Health Marketing (BSC, NCHM), 6402 [2010-2766]
Download as PDF
<![CDATA[
6402
Federal Register / Vol. 75, No. 26 / Tuesday, February 9, 2010 / Notices
II. Electronic Access
Persons with access to the Internet
may obtain the documents at https://
www.fda.gov/BiologicsBloodVaccines/
BloodBloodProducts/Approved
Products/PremarketApprovalsPMAs/
ucm185249.htm
Dated: February 4, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–2757 Filed 2–8–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Health Marketing
(BSC, NCHM)
Cprice-sewell on DSK2BSOYB1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Times and Dates:
9 a.m.–5 p.m., February 25, 2010.
8:30 a.m.–1 p.m., February 26, 2010.
Place: CDC, 2400 Century Parkway,
Building 2400, Room 1A (1023), Atlanta,
Georgia 30345.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 60 people. The
toll free dial-in number is 1 (877) 617–5977
with a pass code of 3468113.
Purpose: The Secretary, Department of
Health and Human Services (HHS), and, by
delegation, the Director, CDC, are authorized
under Section 301 (42 U.S.C. 241) and
Section 311 (42 U.S.C. 243) of the Public
Health Service Act (PHSA), as amended to:
Develop and implement disease prevention
and control, environmental health, and
health promotion and health education
activities designed to improve the health of
the people of the United States. Under these
and additional PHSA and other authorities,
CDC acts by identifying and defining
preventable health problems, maintaining
active surveillance of diseases through
epidemiologic and laboratory investigations
and data collection, analysis, and
distribution; conducting operational research
aimed at developing and testing effective
disease prevention, control, and health
promotion programs; administering a
national occupational safety and health
program; controlling the introduction and
spread of infectious diseases, and providing
consultation and assistance to other nations
and international agencies to assist in
improving their disease prevention and
control, environmental health, and health
promotion activities. CDC carries out these
VerDate Nov<24>2008
14:39 Feb 08, 2010
Jkt 220001
functions through a number of National
Centers, Institutes and Offices with expertise
and responsibilities in specific areas.
Matters To Be Discussed: The agenda will
include: A discussion of the recent
organizational changes at CDC, specifically
presentations on the vision, mission, goals
and organizational structure of the new
Office of Communications; discussions on
program activities, including scientific
programs, that will enable the board to
provide recommendations and advice on the
future course for health communications and
marketing at CDC; and a discussion of focus
areas and new ideas to implement and
expand health marketing science at CDC.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Dionne R. Mason, Committee Management
Specialist, NCHM, CDC, 1600 Clifton Road,
NE., Mail Stop E–21, Atlanta, Georgia 30333;
Telephone: (404) 498–2314, Fax (404) 498–
2221; E-mail: zsu0@cdc.gov. The deadline for
notification of attendance is February 17,
2010.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
application of new technologies; and reviews
the extent to which progress has been made
toward eliminating tuberculosis.
Matters To Be Discussed: Agenda items
include issues pertaining to regionalization
of tuberculosis care; the role of genetics in
tuberculosis; tuberculosis control updates
from the U.S. affiliated Pacific Islands;
tuberculosis research updates; and other
related tuberculosis issues.
Agenda items are subject to change as
priorities dictate.
For More Information Contact: Margie
Scott-Cseh, CDC, 1600 Clifton Road, NE.,
Mail Stop E–07, Atlanta, Georgia 30333,
telephone (404) 639–8317.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: February 1, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–2766 Filed 2–8–10; 8:45 am]
Fogarty International Center; Notice of
Meeting
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis (ACET)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates: 8:30 a.m.–5:30 p.m.,
March 2, 2010. 8:30 a.m.–2:30 p.m., March 3,
2010.
Place: CDC, Corporate Square, Building 8,
1st Floor Conference Room, Atlanta, Georgia
30333, telephone (404) 639–8317.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This council advises and makes
recommendations to the Secretary of Health
and Human Services, the Assistant Secretary
for Health, and the Director, CDC, regarding
the elimination of tuberculosis. Specifically,
the Council makes recommendations
regarding policies, strategies, objectives, and
priorities; addresses the development and
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Dated: February 1, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–2768 Filed 2–8–10; 8:45 am]
BILLING CODE 4163–18–P
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Fogarty
International Center Advisory Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Fogarty International
Center Advisory Board.
E:\FR\FM\09FEN1.SGM
09FEN1
]]>Agencies
[Federal Register Volume 75, Number 26 (Tuesday, February 9, 2010)]
[Notices]
[Page 6402]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-2766]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Health
Marketing (BSC, NCHM)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Times and Dates:
9 a.m.-5 p.m., February 25, 2010.
8:30 a.m.-1 p.m., February 26, 2010.
Place: CDC, 2400 Century Parkway, Building 2400, Room 1A (1023),
Atlanta, Georgia 30345.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 60 people. The toll free
dial-in number is 1 (877) 617-5977 with a pass code of 3468113.
Purpose: The Secretary, Department of Health and Human Services
(HHS), and, by delegation, the Director, CDC, are authorized under
Section 301 (42 U.S.C. 241) and Section 311 (42 U.S.C. 243) of the
Public Health Service Act (PHSA), as amended to: Develop and
implement disease prevention and control, environmental health, and
health promotion and health education activities designed to improve
the health of the people of the United States. Under these and
additional PHSA and other authorities, CDC acts by identifying and
defining preventable health problems, maintaining active
surveillance of diseases through epidemiologic and laboratory
investigations and data collection, analysis, and distribution;
conducting operational research aimed at developing and testing
effective disease prevention, control, and health promotion
programs; administering a national occupational safety and health
program; controlling the introduction and spread of infectious
diseases, and providing consultation and assistance to other nations
and international agencies to assist in improving their disease
prevention and control, environmental health, and health promotion
activities. CDC carries out these functions through a number of
National Centers, Institutes and Offices with expertise and
responsibilities in specific areas.
Matters To Be Discussed: The agenda will include: A discussion
of the recent organizational changes at CDC, specifically
presentations on the vision, mission, goals and organizational
structure of the new Office of Communications; discussions on
program activities, including scientific programs, that will enable
the board to provide recommendations and advice on the future course
for health communications and marketing at CDC; and a discussion of
focus areas and new ideas to implement and expand health marketing
science at CDC.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Dionne R. Mason, Committee
Management Specialist, NCHM, CDC, 1600 Clifton Road, NE., Mail Stop
E-21, Atlanta, Georgia 30333; Telephone: (404) 498-2314, Fax (404)
498-2221; E-mail: zsu0@cdc.gov. The deadline for notification of
attendance is February 17, 2010.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: February 1, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-2766 Filed 2-8-10; 8:45 am]
BILLING CODE 4163-18-P
